|
Showing 1 - 12 of
12 matches in All Departments
Diabetes: Epidemiology, Pathophysiology and Clinical Management
aims to be the one-stop diabetes book for researchers, scientists
and clinicians. It details the epidemiology, causes, molecular
mechanisms, molecular markers, available drugs, experimental drugs,
treatment modalities, and dietary and lifestyle approaches related
to diabetes. It focuses on various molecular aspects of diabetes,
and its related co-morbidities. Apart from the drug-based treatment
approach based on international guidelines, this book also
describes various surgical treatments available for cases of
uncontrolled symptomatic diabetes. It also lays emphasis on the
future possibilities of different approaches for diabetes
management. Key Features Includes treatment guidelines and
approaches to diabetes provided by major global diabetes
associations Provides a thorough and comprehensive assimilation of
detailed information and updates in the field of diabetes, helpful
for researchers, scientists and clinicians Contains a chapter on
anti-diabetic drugs, that covers both the commercially approved
drugs as well as those that are in various phases of experimental,
pre-clinical, and clinical trials
Diabetes: Epidemiology, Pathophysiology and Clinical Management
aims to be the one-stop diabetes book for researchers, scientists
and clinicians. It details the epidemiology, causes, molecular
mechanisms, molecular markers, available drugs, experimental drugs,
treatment modalities, and dietary and lifestyle approaches related
to diabetes. It focuses on various molecular aspects of diabetes,
and its related co-morbidities. Apart from the drug-based treatment
approach based on international guidelines, this book also
describes various surgical treatments available for cases of
uncontrolled symptomatic diabetes. It also lays emphasis on the
future possibilities of different approaches for diabetes
management. Key Features Includes treatment guidelines and
approaches to diabetes provided by major global diabetes
associations Provides a thorough and comprehensive assimilation of
detailed information and updates in the field of diabetes, helpful
for researchers, scientists and clinicians Contains a chapter on
anti-diabetic drugs, that covers both the commercially approved
drugs as well as those that are in various phases of experimental,
pre-clinical, and clinical trials
Pathogenic Viruses and Armamentarium Design covers the latest
developments in viral target elucidation and viral control using
wet and dry lab strategies. The control and combat strategies and
their implementation compiled in this book are a valuable aid in
understanding viral disease progression and designing new
strategies against existing and evolving viruses. This important
resource is a comprehensive compilation of anti-viral approaches
designed and devised using computational and other laboratory
techniques. The content targets the readership of college students,
scientists and research investigators working on the pathogenic
virus and development of prophylactics and therapeutics against
viral infection. Researchers from biotechnology, infection biology,
chemistry and pharmaceutical science will surely benefit from this
content. The incorporation of software and tools will also help
both experienced and new bioinformaticians and students.
Developments of antifungal agents have declined as compared to
other antibiotics that have displayed a potent development with
time. There is an urgent need for both prophylactic and therapeutic
treatments worldwide to control the severity of infections caused
by Candida. Anticandidal Therapeutics provides the readers with a
compiled knowledge of the fungal human infection Candida and the
development of anticandidal drugs. Anticandidal Therapeutics helps
researchers form the basis for the discovery and development of
novel anticandidal therapies. In 14 chapters this book provides
collective information on anticandidal agents and their discovery
and development with respect to major drug transporter families,
different stages of anticandidal agent development, recent trends
and progress in antifungal translational research, clinical studies
status of anticandidal therapeutic agents, and drug repurposing for
development of novel anticandidal agents.
Leishmania-related illnesses remain among the world s deadliest
neglected tropical diseases, affecting approximately 12 million
people in 88 countries.The mortality rate is substantial,
contributing to nearly two million disability-adjusted life years.
As more is understood about this parasite and its effects, work
toward prevention, control, and treatment continues
apace."Leishmania and Leishmaniasis" will address the parasite and
its attendant disease, which manifests in three syndromes: Visceral
(VL), Cutaneous (CL) and Mucocutaneous Leishmaniasis (ML). The
morphology and life cycles of the various species will be among the
topics addressed in Part One. Part Two will focus on immunology,
including host-immune response to Leishmania infection,
cross-immunity between the different species and adoptive transfer
of immunity. Parts Three and Four will address how Leishmania
invade and survive, the clinical features of the disease, and its
diagnosis.Drugs, vaccines and treatment will be thoroughly
explored, including experimental models of therapeutics.
"Leishmania and Leishmaniasis" will provide a thorough examination
of a parasite, the illnesses it causes and the misery it continues
to visit upon large segments of the population. "
Visceral Leishmaniasis: Therapeutics and Vaccines describes current
therapeutics, natural anti-leishmanial molecules, anti-leishmanial
screening, and explores vaccine candidates and amastigote-based
vaccination strategies for Leishmania. The book provides a precise
view on VL, Leishmania parasite culture, host immunity and
immunomodulation, natural compounds effective against VL, animal
models for VL, and methodologies available for anti-leishmanial
drug screening procedures against VL, as well as vaccine and
vaccination-related information on Leishmaniasis. Readers will find
concrete information on past and current hurdles facing vaccine
development for Leishmania, along with scientific opportunities and
the potential impact of vaccines, including problems encountered.
The book is designed to increase the understanding of vaccines,
particularly in VL, for students and researchers. Although vaccines
are now available for many diseases, there are still challenges
ahead for a vaccine for VL. The ideal vaccine must be safe and able
to induce an immune response that is strong and effective. In a
nutshell, a combination of chemotherapy (drugs) and
immunoprophylaxis (vaccine) would be ideal to win the battle
against VL.
Phytoconstituents and Antifungals covers a wide range of specific
information on various phytoconstituents, their antifungal mode and
the diagnosis and management of fungal infections. The book offers
encouragement and empowers readers to re-embrace their knowledge of
phytoconstituents and their various antifungal activities against
most opportunistic pathogenic fungi as fungal diseases cause an
estimated 1.5+ million deaths annually and over one billion people
suffer from severe fungal disease. In this complex scenario, it is
now clear that global warming and accompanying climate changes have
resulted in increased incidence of many fungal infections. On the
basis of all these factors, concerns on the occurrence of a
pandemic fungal origin in the near future have been raised. In this
context, to stop forgetting and underestimating fungal diseases is
mandatory.
Antimicrobial Resistance in Wastewater and Human Health provides
updated knowledge on the human health risks associated with
antimicrobial resistance of wastewater. The book's chapters address
commonly found bacteria and drug resistant genes in wastewater,
treatment plant problems and challenges, human health hazards, and
gaps in current literature. Written for researchers, scientists,
graduate and PhD students in the areas of Public Health,
Biotechnology, Chemical Engineering, and Environmental Science,
this will be an ideal resource.
Anticandidal Agents provides the latest information on candida drug
resistance and its remedial implications. In this compilation,
users will find a comprehensive view on overcoming resistance in
anticandidal drugs, along with information on novel molecules.
Candida albicans is an opportunistic pathogenic fungus responsible
for life threating invasive and nosocomial infections across the
globe. Candidiasis is a major cause of morbidity among
immunocompromised patients. Infections caused by non-albicans
candida like C. glabrata, C. parapsilosis, and C. tropicalis have
also imposed a serious threat in the last few decades. Current
treatment of candidiasis relies primarily on antifungal agents
broadly categorized as azoles, polyenes, echinocandins,
allylamines, and pyrimidines. Lately, antifungal resistance has
emerged to be an obstruction of current treatment regime. A number
of reasons are described in detail. Understanding the mechanisms of
resistance is crucial for developing strategies for overcoming the
hindrance in current therapeutics.
Hydrogel is a network of polymer chains, sometimes found as a
colloidal gel form in which water is the dispersion medium. Present
study evaluated the cell viability and cytotoxicity of the
hydrogel, thereby providing preliminary information for further
studies on systemic toxicities. In order to perform a convincing
evaluation of the cytotoxicity of the hydrogel, various experiment
concerning different aspects of cell damage were used which is
described in detail in this book. It may open new regimes for the
early detection and treatment of a number of diseases ranging from
infectious disease to cancer. Studies on toxicity and
pharmacokinetics of these hydrogel in in-vivo system could be
further assessed.
Over the last decade, attention has been increased to develop the
systems to deliver gene and drugs for long periods at specific site
and controlled rates without any side effects. But up till now
current therapy has not such type of property and we required the
more sophisticated method to deliver gene/drug. Biocompatible
biomaterials such as natural polymer, liposomes, hydrogels,
microspheres, dendrimers, chitosan, nanowires, nanotubes etc. or
its derivatives are the most promising and act as the carrier for
the delivery of DNA and drug molecules. Emphasis of this book is on
Biomaterials and its uses which could play a major in treating a
lot of biological complications, diseases and other applications.
Cellulase is a multienzyme system responsible for hydrolysis of
cellulose to glucose. It is commercially very important enzyme for
the generation of glucose from lignocellulosic waste. Production of
glucose is commercially viable process for the direct conversion of
cellulosic material to glucose. Cellulase can be synthesized and
purified by the growth of A. niger and other microbes under
optimized condition which could be used for the production of
glucose, ethanol etc from lignocellulosic waste for the benefit of
mankind.
|
You may like...
Loot
Nadine Gordimer
Paperback
(2)
R398
R330
Discovery Miles 3 300
Personal Shopper
Kristen Stewart, Nora von Waldstätten, …
DVD
R86
Discovery Miles 860
|